18 /100
LOW RISK
Score updated May 28, 2026

GMED — Globus Medical, Inc. Dilution Risk Tracker

Track GMED dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GMED — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration 15%
• Score climbed 8 points (worsening)
🔔 Track GMED — Get forecast alerts →

💹 Market Data

Market Cap$11.21B
Shares Outstanding113.31M
Float111.72M
Cash$629.85M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 7.2% shares (2025Q4 vs prior)
562 institutional holders · 116.61M shares
#1 VANGUARD GROUP INC 10.55M shares
#2 BlackRock, Inc. 10.28M shares
#3 JANUS HENDERSON GROUP PLC 7.29M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.12M
Days to Cover3.5
% of Float2.8%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track GMED Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GMED — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for GMED
📊 GMED FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 GMED Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.